Alexandra Lansky

Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome

Hassanin A, Brener S, Lansky A, Xu K, Stone G

July 20, 2015 | 10.4244/EIJY14M08_05

Will this trial change my practice? TOTAL: a randomised trial of thrombus aspiration in ST-elevation myocardial infarction

Behan M, Haude M, Oldroyd K, Lansky A, James S, Baumbach A

July 20, 2015 | 10.4244/EIJV11I3A70

Tools and Techniques - Clinical: Embolic protection devices in transcatheter aortic valve implantation

van Gils L, Baumbach A, Himbert D, Lansky A, Vahanian A, Van Mieghem N

June 19, 2015 | 10.4244/EIJV11I2A45

Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study

Baumbach A, Mullen M, Brickman A, Aggarwal S, Pietras C, Forrest J, Hildick-Smith D, Meller S, Gambone L, den Heijer P, Margolis P, Voros S, Lansky A

May 19, 2015 | 10.4244/EIJY15M04_01

Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial

Wijns W, Vrolix M, Verheye S, Schoors D, Slagboom T, Gosselink M, Benit E, Donohoe D, Knape C, Attizzani G, Lansky A, Ormiston J

April 20, 2015 | 10.4244/EIJY14M05_03

Will this trial change my practice? TASTE - a randomised registry on thrombus aspiration in primary PCI with a 30-day endpoint

Behan M, Lansky A, Jolly SS, Baumbach A

July 21, 2014 | 10.4244/EIJV10I3A68

Will this trial change my practice? PRAMI - treatment of bystander coronary lesions in patients undergoing primary PCI for acute STEMI

Toth G, Kala P, Lansky A, Baumbach A

July 21, 2014 | 10.4244/EIJV10I3A70

Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)

Dudek D, Mehran R, Dziewierz A, Brener S, Rakowski T, Brzeziński M, Brodie B, Xu K, Fahy M, Lansky A, Zmudka K, Stone G

November 29, 2013 | 10.4244/EIJV9I7A135

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley SG, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky A, Bichalska M, Meis S, Verheye S

September 27, 2013 | 10.4244/EIJV9I5A93

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial

Caixeta A, Lansky A, Mehran R, Brener S, Claessen B, Généreux P, Palmerini T, Witzenbichler B, Guagliumi G, Brodie B, Dudek D, Fahy M, Dangas G, Stone G

June 28, 2013 | 10.4244/EIJV9I2A37

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C, Han Y, Chen S, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial

Rakowski T, Dudek D, Dziewierz A, Yu J, Witzenbichler B, Guagliumi G, Kornowski R, Hartmann F, Lansky A, Brener S, Mehran R, Stone G

March 22, 2013 | 10.4244/EIJV8I11A199

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, De Bruyne B, Serruys P, Stone G

December 28, 2012 | 10.4244/EIJV8I8A142

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

Généreux P, Mehran R, Palmerini T, Caixeta A, Kirtane A, Lansky A, Brodie B, Witzenbichler B, Mockel M, Guagliumi G, Peruga J, Dudek D, Fahy M, Dangas G, Stone G

December 30, 2011 | 10.4244/EIJV7I8A144

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Hermiller J, Nikolsky E, Lansky A, Applegate R, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone G

July 29, 2011 | 10.4244/EIJV7I3A54

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Lansky A, Yaqub M, Hermiller J, Smith R, Farhat N, Caputo R, Williams J, Sanz M, Koo K, Sood P, Sudhir K, Stone G

January 11, 2011

Mesh covered stent in ST-segment elevation myocardial infarction

Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky A, Siudak Z, Zmudka K

November 15, 2010

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial

Applegate R, Hermiller J, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky A, Sudhir K, Stone G

September 30, 2010

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

Seth A, Serruys P, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone G

February 25, 2010

Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial

Nikolsky E, Stone G, Lee E, Lansky A, Webb J, Cox D, Brodie B, Turco M, Rutherford B, Kalynych A, Antoniucci D, Krucoff M, Gibbons R, Fahy M, Mehran R

September 30, 2009

Alexandra Lansky

Latest news